To order this 180+page report, which features 90+ figures and 85+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/peptides-and-macrocycle-discovery/300.html
TheUSD 1.5 billion (by 2030) financial opportunity within the peptides andmacrocycles drug discovery service and platform providers market has beenanalyzed across the following segments:
§ Type of peptides
§ Synthetic peptides
§ Biologic andrecombinant peptides
§ Type of discoverysteps
§ Target identificationand validation
§ Hit identification
§ Lead generation
§ Lead optimization
§ Therapeutic Area
§ Oncological disorders
§ Metabolic disorders
§ Cardiovasculardisorders
§ Infectious diseases
§ Urological disorders
§ Endocrine disorders
§ CNS disorders
§ Other diseases
§ Company Size
§ Small companies
§ Mid-sized companies
§ Large and very largecompanies
§ Key geographicalregions
- Europe
- North America
- Asia-Pacific and the Rest of the World
Thereport features inputs from eminent industry stakeholders, according to whompeptide and macrocycles drug discovery outsourcing market is continuouslypacing up. The report includes detailed transcripts of discussions held withthe following experts:
§ Mark I Peterson (CEO,CycleniumPharma)
§ Jan Hoflack (Chief Scientific Officer, Head ofBiotech Business Unit, Oncodesign)
Theresearch covers profiles of key players that offer peptides and macrocyclicdrugs discovery platforms and services, featuring an overview of the company,its service portfolio / technology platform, and an informed future outlook.
§ GenScript
§ JPT PeptideTechnologies
§ CPC Scientific
§ IRBM
§ Creative Peptides
§ Pepscan
§ Interprotein
§ RA Pharmaceuticals
§ Pepticom
§ PeptiDream
§ Creative Biolabs
§ MeSCue-Janusys
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Market Landscape ofService Providers
5. Benchmark Analysis
6. Market Landscape of PlatformProviders
7. Company Profiles
8. Partnerships
9. Market Forecast andOpportunity Analysis
10. SWOT Analysis
11. Conclusion
12. Executive Insights
13. Appendix 1: List ofCompanies and Organizations
14. Appendix 1: Tabulated Data
To purchase a copy,please visit https://www.rootsanalysis.com/reports/view_document/immune-checkpoint-inhibitors/303.html
Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
gaurav.chaudhary@rootsanalysis.com
